Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review

Immunotherapy in ovarian cancer

Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy

Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease

Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer

Dendritic cell vaccination against ovarian cancer–tipping the Treg/TH17 balance to therapeutic advantage?